About Mary Morris, MD, PhD

Mary Morris, MD, PhD, is the Medical Director of the Oncofertility Clinic and the Medical Director of the Third-Party Reproduction Program in the Reproductive Endocrinology and Infertility Division of the Department of Obstetrics and Gynecology at Massachusetts General Hospital. She is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School.

Her primary research interests include exploring novel approaches to fertility preservation in those diagnosed with cancer and understanding clinical outcomes for women with hereditary cancer syndromes.

Clinical Interests:



Boston: Massachusetts General Hospital

Mass General Fertility Center
55 Fruit St.
Yawkey Center for Outpatient Care
Suite 10A
Boston, MA 02114
Phone: 617-726-8868

View location, directions and parking information for Mass General

Danvers: The Mass General/North Shore Center for Outpatient Care

Mass General Obstetrics & Gynecology at Mass General/North Shore Center for Outpatient Care
102-104 Endicott St.
Suite 304
Danvers, MA 01923
Phone: 978-882-6767

View location, directions and parking information for Mass General/North Shore Center for Outpatient Care

Medical Education

  • MD, Columbia Univ. College of Physicians & Surgeons
  • MD, Columbia University College of Physicians & Surgeons
  • PhD, Harvard University
  • PhD, Harvard University Graduate School of Arts And Sciences
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
  • Reproductive Endo. & Infertility, American Board of Obstetrics and Gynecology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


  • Selected publications:

    Kano M, Sosulski AE, Zhang L, Saatcioglu HD, Wang D, Nagykery N, Sabatini ME, Gao G, Donahoe PK, Pépin D. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy. Proceedings of the National Academy of Sciences USA. 2017 Feb 28;114(9):E1688-E1697.

    Mínguez-Alarcón L, Chiu YH, Messerlian C, Williams PL, Sabatini ME, Toth TL, Ford JB, Calafat AM, Hauser R; EARTH Study Team. Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic. Fertility & Sterility. 2016 Mar;105(3):714-21.

    Hariton E, Bortoletto P, Cardozo ER, Hochberg EP, Sabatini ME. The Role of Oncofertility Clinics in Facilitating Access to Reproductive Specialists. 
    Accepted and awaiting publication in Journal of Patient Experience

    Cardozo E, Karmon A, Longacre MM and Sabatini ME. The Role of Demographics and Diagnosis on Fertility Preservation Decision Making Among Female Cancer Patients of Reproductive Age. Accepted and awaiting publication in Journal of Reproductive Medicine

    Hariton E, Kim K, Mumford SL, Palmor M, Bortoletto P, Cardozo ER, Karmon A, Sabatini ME, Styer AK. Total number of Oocytes and Zygotes are Predictive of Live Birth Pregnancy in Fresh Donor Oocyte IVF Cycles
    Accepted for publication  2017 – Fertility & Sterility

    "Fertility and Cancer: Fertility Preservation and Fertility Sparing Surgery" (Chapter 15) in Translational Advances in Gynecologic Cancers (1st Edition, 2017)
    Editors: Michael Birrer & Lorenzo Ceppi

     See more publications on PubMed.


Reviews: Comments and Ratings